Drug name - Rukobia

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8461333 VIIV HLTHCARE Salts of prodrugs of piperazine and substituted piperidine antiviral agents
Feb, 2025

(2 years from now)

US7745625 VIIV HLTHCARE Prodrugs of piperazine and substituted piperidine antiviral agents
Nov, 2027

(5 years from now)

CN101941990B VIIV HLTHCARE Piperazine And Prodrug Of Substituted Piperidine Antiviral Drug
Mar, 2025

(2 years from now)

CN1953985A VIIV HLTHCARE Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents
Mar, 2025

(2 years from now)

CN101941990A VIIV HLTHCARE Pyrazine Antiviral Drug And Prodrug Of Piperazine And Substituted
Mar, 2025

(2 years from now)

CN1953985B VIIV HLTHCARE Piperazine And Prodrug Of Substituted Piperidine Antiviral Drug
Mar, 2025

(2 years from now)

IN200605355P1 VIIV HLTHCARE Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents
Mar, 2025

(2 years from now)

IN254948B VIIV HLTHCARE A Compound Of Formula I
Mar, 2025

(2 years from now)

EP1725569B1 VIIV HLTHCARE Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents
Mar, 2025

(2 years from now)

EP1725569A1 VIIV HLTHCARE Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents
Mar, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8168615 VIIV HLTHCARE Prodrugs of piperazine and substituted piperidine antiviral agents Feb, 2025

(2 years from now)

Drugs and Companies using FOSTEMSAVIR TROMETHAMINE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 600MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.